BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32640310)

  • 1. miR-655: A promising regulator with therapeutic potential.
    Li H; Zhang J; Yang Y; Duan S
    Gene; 2020 Oct; 757():144932. PubMed ID: 32640310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functions and mechanisms of miR-186 in human cancer.
    Wang Z; Sha HH; Li HJ
    Biomed Pharmacother; 2019 Nov; 119():109428. PubMed ID: 31525641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The miR-15a/16 gene cluster in human cancer: A systematic review.
    Liu T; Xu Z; Ou D; Liu J; Zhang J
    J Cell Physiol; 2019 May; 234(5):5496-5506. PubMed ID: 30246332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic, prognostic role and molecular mechanism of miR-328 in human cancer.
    Wang Z; Xie W; Guan H
    Biomed Pharmacother; 2023 Jan; 157():114031. PubMed ID: 36413837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
    Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of microRNAs in endocrine cancer metastasis.
    Lima CR; Gomes CC; Santos MF
    Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
    Zheng M; Sun X; Li Y; Zuo W
    Tumour Biol; 2016 Jun; 37(6):8189-96. PubMed ID: 26715279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of miR-100 in cancer diagnosis, prognosis, and therapy.
    Qin C; Huang RY; Wang ZX
    Tumour Biol; 2015 Mar; 36(3):1403-9. PubMed ID: 25740059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.
    Liu B; Tian Y; Li F; Zhao Z; Jiang X; Zhai C; Han X; Zhang L
    Oncol Rep; 2016 Jun; 35(6):3178-84. PubMed ID: 27109339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
    Sun G; Liu M; Han H
    J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy.
    Alizadeh M; Safarzadeh A; Beyranvand F; Ahmadpour F; Hajiasgharzadeh K; Baghbanzadeh A; Baradaran B
    J Cell Physiol; 2019 Nov; 234(11):19280-19297. PubMed ID: 30950056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
    Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
    BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional role of miR-34 family in human cancer.
    Wang R; Ma J; Wu Q; Xia J; Miele L; Sarkar FH; Wang Z
    Curr Drug Targets; 2013 Sep; 14(10):1185-91. PubMed ID: 23834144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of miR-638 in the progression of cancers.
    Chong ZX; Yeap SK; Ho WY
    Pathol Res Pract; 2021 Apr; 220():153351. PubMed ID: 33642053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
    Humphries B; Yang C
    Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
    Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
    Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer.
    Eissa S; Matboli M; Shehata HH
    Transl Res; 2015 Mar; 165(3):417-27. PubMed ID: 25445205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Regulatory Mechanism of miR-574-5p Expression in Cancer.
    Huang W; Zhao Y; Xu Z; Wu X; Qiao M; Zhu Z; Zhao Z
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.